Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.1%

3 terminated out of 33 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

17%

3 of 18 completed with results

Key Signals

3 with results86% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (11)
P 2 (3)
P 3 (1)

Trial Status

Completed18
Unknown4
Recruiting4
Terminated3
Active Not Recruiting2
Not Yet Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT04785937Not ApplicableCompleted

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

NCT04682600Not ApplicableCompleted

The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF

NCT03139058Not ApplicableTerminatedPrimary

Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT04155398Active Not RecruitingPrimary

EUS Elastography for Predicting Cirrhotic-related Complications

NCT04666402Recruiting

Integrated Diagnostics for Early Diagnosis of Liver Disease

NCT03149627Completed

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

NCT03483584Completed

Incidence of HANA Conditions in HIV-infected Individuals

NCT04820036Not ApplicableActive Not Recruiting

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

NCT05028829Phase 2RecruitingPrimary

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

NCT07145268Phase 2Not Yet RecruitingPrimary

Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

NCT04389593Completed

Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference

NCT04277819Completed

The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management

NCT03598283Withdrawn

Liver, Pancreas and Thyroid Function in Burn Patients

NCT04579874Not ApplicableCompleted

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

NCT03042520UnknownPrimary

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

NCT04115046CompletedPrimary

The EUS ShearWave Elastography Liver Fibrosis Study

NCT05008263CompletedPrimary

Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis

NCT02279524Phase 2Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

NCT04677101Completed

Liquid Biopsy for NASH and Liver Fibrosis

NCT04791397Not ApplicableCompleted

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Scroll to load more

Research Network

Activity Timeline